The rise of GLP-1 injectable medications, such as those used for diabetes management and weight loss, has been nothing short of a pharmaceutical phenomenon. In 2023 alone, the demand for GLP-1 meds skyrocketed, with global sales expected to exceed $12 billion by 2025, according to a report by Fortune Business Insights. It shows that there are more patients embracing injectables as part of their health and wellness journey. ...